The advent of high-density recording technologies, such as Neuropixels and large-scale calcium imaging, has provided an unprecedented look into the ...

Bio (NASDAQ:IBIO) is seeking to narrow what it views as a growing “trust gap” between the promise of generative AI in drug discovery and the high cost and long timelines of bringing a drug to market, ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. This voice experience is generated by AI. Learn more. This ...

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

While precision seems critical for science, researchers from the U.S. Department of Energy's (DOE) Brookhaven National ...

You can hear AI give you mental health advice, rather than merely seeing the advice via text. Think of the real-time upside.

The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the ...

Shadow AI 2.0 isn’t a hypothetical future, it’s a predictable consequence of fast hardware, easy distribution, and developer ...

They "preserve the unique soul of your work," Deepa Subramaniam says ...

According to MarketsandMarkets™, the Generative AI Server Market is expected to reach USD 448.60 billion by 2030 from USD 103.92 billion in 2025, registering a CAGR of 34.0% during the forecast period ...